Glenmede Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42.1M | Buy |
85,674
+217
| +0.3% | +$118K | 0.21% | 92 |
|
|
2025
Q4 | $49.5M | Buy |
+85,457
| New | +$48.3M | 0.23% | 86 |
|
|
2025
Q1 | $48M | Buy |
96,443
+16,331
| +20% | +$8.84M | 0.26% | 81 |
|
|
2024
Q4 | $41.7M | Sell |
80,112
-9,321
| -10% | -$5.12M | 0.21% | 103 |
|
|
2024
Q3 | $55.3M | Sell |
89,433
-6,486
| -7% | -$3.84M | 0.26% | 84 |
|
|
2024
Q2 | $53M | Sell |
95,919
-817
| -0.8% | -$468K | 0.27% | 84 |
|
|
2024
Q1 | $56.2M | Buy |
96,736
+27,437
| +40% | +$15.4M | 0.28% | 87 |
|
|
2023
Q4 | $36.8M | Sell |
69,299
-5,035
| -7% | -$2.44M | 0.19% | 116 |
|
|
2023
Q3 | $37.6M | Sell |
74,334
-519
| -0.7% | -$277K | 0.22% | 107 |
|
|
2023
Q2 | $43.1M | Hold |
74,853
| – | – | 0.24% | 102 |
|
|
2023
Q1 | $43.1M | Sell |
74,853
-482
| -0.6% | -$272K | 0.24% | 102 |
|
|
2022
Q4 | $41.5M | Sell |
75,335
-58,004
| -44% | -$30.7M | 0.24% | 102 |
|
|
2022
Q3 | $67.6M | Sell |
133,339
-10,274
| -7% | -$5.75M | 0.43% | 57 |
|
|
2022
Q2 | $78M | Buy |
143,613
+9,230
| +7% | +$5.08M | 0.46% | 51 |
|
|
2022
Q1 | $79.4M | Buy |
134,383
+27,407
| +26% | +$15.7M | 0.39% | 64 |
|
|
2021
Q4 | $71.4M | Sell |
106,976
-1,396
| -1% | -$872K | 0.34% | 75 |
|
|
2021
Q3 | $61.9M | Sell |
108,372
-20,314
| -16% | -$11.1M | 0.32% | 82 |
|
|
2021
Q2 | $64.9M | Buy |
128,686
+8,384
| +7% | +$3.96M | 0.34% | 77 |
|
|
2021
Q1 | $54.9M | Buy |
120,302
+72,662
| +153% | +$34.7M | 0.3% | 90 |
|
|
2020
Q4 | $22.2M | Buy |
47,640
+928
| +2% | +$435K | 0.12% | 200 |
|
|
2020
Q3 | $20.6M | Buy |
46,712
+4,065
| +10% | +$1.68M | 0.12% | 188 |
|
|
2020
Q2 | $15.5M | Sell |
42,647
-394
| -0.9% | -$132K | 0.09% | 252 |
|
|
2020
Q1 | $14M | Hold |
43,041
| – | – | 0.06% | 322 |
|
|
2019
Q4 | $14M | Buy |
43,041
+3,353
| +8% | +$1.02M | 0.06% | 322 |
|
|
2019
Q3 | $11.6K | Buy |
39,688
+1,380
| +4% | +$395K | 0.05% | 341 |
|
|
2019
Q2 | $11.2K | Buy |
38,308
+1,684
| +5% | +$464K | 0.05% | 359 |
|
|
2019
Q1 | $10K | Sell |
36,624
-16,525
| -31% | -$4.11M | 0.05% | 368 |
|
|
2018
Q4 | $11.9K | Buy |
53,149
+4,509
| +9% | +$1.06M | 0.06% | 331 |
|
|
2018
Q3 | $11.9M | Sell |
48,640
-191,413
| -80% | -$44M | 0.05% | 363 |
|
|
2018
Q2 | $49.7M | Sell |
240,053
-296,544
| -55% | -$62.9M | 0.22% | 135 |
|
|
2018
Q1 | $102M | Hold |
536,597
| – | – | 0.42% | 58 |
|
|
2017
Q4 | $102M | Buy |
536,597
+20,179
| +4% | +$3.87M | 0.42% | 58 |
|
|
2017
Q3 | $97.7M | Sell |
516,418
-219,922
| -30% | -$39.8M | 0.43% | 58 |
|
|
2017
Q2 | $113M | Hold |
736,340
| – | – | 0.54% | 31 |
|
|
2017
Q1 | $113M | Buy |
736,340
+23,280
| +3% | +$3.56M | 0.54% | 31 |
|
|
2016
Q4 | $101M | Buy |
713,060
+132,942
| +23% | +$19.6M | 0.55% | 33 |
|
|
2016
Q3 | $92.3M | Buy |
580,118
+166,391
| +40% | +$25.6M | 0.52% | 38 |
|
|
2016
Q2 | $61.1M | Buy |
413,727
+7,163
| +2% | +$1.06M | 0.37% | 62 |
|
|
2016
Q1 | $57.6M | Sell |
406,564
-82,316
| -17% | -$11M | 0.37% | 59 |
|
|
2015
Q4 | $69.3M | Sell |
488,880
-22,736
| -4% | -$3.03M | 0.47% | 46 |
|
|
2015
Q3 | $62.6M | Buy |
511,616
+208,566
| +69% | +$27.2M | 0.46% | 43 |
|
|
2015
Q2 | $39.3M | Buy |
303,050
+191,305
| +171% | +$24.9M | 0.28% | 93 |
|
|
2015
Q1 | $15M | Buy |
111,745
+32,714
| +41% | +$4.22M | 0.11% | 291 |
|
|
2014
Q4 | $9.9M | Buy |
79,031
+1,895
| +2% | +$230K | 0.08% | 345 |
|
|
2014
Q3 | $9.38M | Sell |
77,136
-10,877
| -12% | -$1.32M | 0.08% | 317 |
|
|
2014
Q2 | $10.4M | Buy |
88,013
+1,277
| +1% | +$150K | 0.09% | 298 |
|
|
2014
Q1 | $10.4M | Sell |
86,736
-6,936
| -7% | -$825K | 0.1% | 283 |
|
|
2013
Q4 | $10.4M | Buy |
93,672
+30,729
| +49% | +$3.06M | 0.11% | 265 |
|
|
2013
Q3 | $5.8M | Sell |
62,943
-30,186
| -32% | -$2.73M | 0.07% | 325 |
|
|
2013
Q2 | $7.88M | Buy |
+93,129
| New | +$7.75M | 0.1% | 233 |
|
Other funds holding TMO
VCM
Glenmede Trust's TMO Position: Q1 2026 in Review
Glenmede Trust increased its Thermo Fisher Scientific (TMO) stake by 0.25% in Q1 2026, buying an estimated $118K and bringing the position to 85,674 shares worth $42.1M. The position accounts for 0.21% of the portfolio, ranked #92.
Glenmede Trust first reported a position in TMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $113M in Q2 2017. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Glenmede Trust held 85,674 shares of Thermo Fisher Scientific worth $42.1M as of Q1 2026.
- Glenmede Trust bought 217 Thermo Fisher Scientific shares in Q1 2026, an estimated $118K.
- Thermo Fisher Scientific made up 0.21% of Glenmede Trust's portfolio in Q1 2026, its #92 holding.
- Glenmede Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's Thermo Fisher Scientific position peaked at $113M in Q2 2017.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.